Disclosures for "Endovascular Thrombectomy Versus Medical Management for Large Vessel Occlusion Stroke Patients with Severe Baseline Disability")
-
Dr. Awad has nothing to disclose.
-
Dr. Young has nothing to disclose.
-
Dr. Andreev has nothing to disclose.
-
Dr. Dmytriw has nothing to disclose.
-
Dr. Vranic has nothing to disclose.
-
James D. Rabinov has stock in Pfizer.
-
Dr. Stapleton has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Zoll Circulation.
-
Dr. Das has nothing to disclose.
-
An immediate family member of Dr. Singhal has received personal compensation for serving as an employee of Biogen. Dr. Singhal has received personal compensation in the range of $5,000-$9,999 for serving as an Expert Witness for Medicolegal Firms. Dr. Singhal has received research support from NIH-NINDS. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received publishing royalties from a publication relating to health care. Dr. Singhal has received personal compensation in the range of $500-$4,999 for serving as a Honorarium (Education) with Biogen.
-
Dr. Rost has received personal compensation in the range of $5,000-$9,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Stroke - AHA/ASA Journal. The institution of Dr. Rost has received research support from NIH. Dr. Rost has received publishing royalties from a publication relating to health care.
-
Aman Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Penumbra. Aman Patel has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for Microvention. Aman Patel has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Medtronic. The institution of Aman Patel has received research support from Siemens.
-
Dr. Regenhardt has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Rapid Medical. The institution of Dr. Regenhardt has received research support from NINDS. The institution of Dr. Regenhardt has received research support from SVIN.